FAQsVolume 10 Issue 7
July-2023
eISSN: 2349-5162
- Share us
-
-
-
Journal of Emerging Technologies and Innovative Research ( An International Scholarly Open Access Journal, Peer-reviewed, Refereed Journal )
Impact factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal
UGC Approved Journal no 63975(19)
ISSN: 2349-5162 | ESTD Year : 2014 Call for Paper
Volume 11 | Issue 5 | May 2024
ISSN: 2349-5162 | ESTD Year : 2014 Call for Paper
Volume 11 | Issue 5 | May 2024
JETIREXPLORE- Search Thousands of research papers
Contact Us Click Here
WhatsApp Contact Click Here
Published in:
UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975
Unique Identifier
Published Paper ID:
JETIR2307592
Registration ID:
521584
Page Number
Important Links:
Jetir RMS
Title
PHARMACOVIGILANCE : STUDY OF PARKINSON'S DISEASE AND ADVERSE DRUG REACTION REPORTING ON ANTIPARKINSON'S MEDICATION LEVODOPA+CARBIDOPA
Abstract
Parkinson’s complaint is a progressive, neurodegenerative complaint of growing that affects both motor and cognitive function. The etiology of Parkinson’s disease is substantially unknown, but it probably involves both inheritable and terrain factor. In contrast ,the network –level pathology motor symptoms of Parkinson’s The most prescribed medication to treat is (Levodopa+Carbidopa) are given in combined form giving effective pharmacological action and also includes majority of adverse drug reaction like dyskinesia, sedation, constipation etc.
Key Words
Pharmacovigilance, Adverse Drug Reaction, Parkinson’s, Levodopa+Carbidopa
Cite This Article
"PHARMACOVIGILANCE : STUDY OF PARKINSON'S DISEASE AND ADVERSE DRUG REACTION REPORTING ON ANTIPARKINSON'S MEDICATION LEVODOPA+CARBIDOPA", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 7, page no.f730-f735, July-2023, Available :http://www.jetir.org/papers/JETIR2307592.pdf
ISSN
2349-5162 | Impact Factor 7.95 Calculate by Google Scholar
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Cite This Article
"PHARMACOVIGILANCE : STUDY OF PARKINSON'S DISEASE AND ADVERSE DRUG REACTION REPORTING ON ANTIPARKINSON'S MEDICATION LEVODOPA+CARBIDOPA", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 7, page no. ppf730-f735, July-2023, Available at : http://www.jetir.org/papers/JETIR2307592.pdf
Publication Details
Published Paper ID: JETIR2307592
Registration ID: 521584
Published In: Volume 10 | Issue 7 | Year July-2023
Page No: f730-f735
Country: Gadhingalaj, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication
Published Paper URL :: https://www.jetir.org/view?paper=JETIR2307592
Published Paper PDF: https://www.jetir.org/papers/JETIR2307592
Download Paper / Preview Article
Download Paper
Preview This Article
Download PDF
Downloads
00099
Print This Page
Important Links:
Jetir RMS
